113 related articles for article (PubMed ID: 24970329)
21. Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer.
Wei H; Li F; Fu P; Liu X
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):436-46. PubMed ID: 23467940
[TBL] [Abstract][Full Text] [Related]
22. Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer.
Tiffon C
Pancreas; 2018 Feb; 47(2):200-207. PubMed ID: 29303911
[TBL] [Abstract][Full Text] [Related]
23. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
24. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
25. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
[TBL] [Abstract][Full Text] [Related]
26. N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620.
Li Q; Chen H
Clin Exp Metastasis; 2011 Feb; 28(2):127-35. PubMed ID: 21184144
[TBL] [Abstract][Full Text] [Related]
28. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
29. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1.
Geleta B; Tout FS; Lim SC; Sahni S; Jansson PJ; Apte MV; Richardson DR; Kovačević Ž
J Biol Chem; 2022 Mar; 298(3):101608. PubMed ID: 35065073
[TBL] [Abstract][Full Text] [Related]
30. N-myc downstream regulated 1 gene and its place in the cellular machinery.
Kitowska A; Pawełczyk T
Acta Biochim Pol; 2010; 57(1):15-21. PubMed ID: 20300662
[TBL] [Abstract][Full Text] [Related]
31. Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors.
Sun J; Zhang D; Bae DH; Sahni S; Jansson P; Zheng Y; Zhao Q; Yue F; Zheng M; Kovacevic Z; Richardson DR
Carcinogenesis; 2013 Sep; 34(9):1943-54. PubMed ID: 23671130
[TBL] [Abstract][Full Text] [Related]
32. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
33. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
[TBL] [Abstract][Full Text] [Related]
34. A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1).
Jiang K; Shen Z; Ye Y; Yang X; Wang S
Scand J Gastroenterol; 2010 Aug; 45(7-8):898-908. PubMed ID: 20388062
[TBL] [Abstract][Full Text] [Related]
35. The role of NDRG1 in the pathology and potential treatment of human cancers.
Bae DH; Jansson PJ; Huang ML; Kovacevic Z; Kalinowski D; Lee CS; Sahni S; Richardson DR
J Clin Pathol; 2013 Nov; 66(11):911-7. PubMed ID: 23750037
[TBL] [Abstract][Full Text] [Related]
36. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
38. Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer.
Angst E; Sibold S; Tiffon C; Weimann R; Gloor B; Candinas D; Stroka D
Br J Cancer; 2006 Aug; 95(3):307-13. PubMed ID: 16832411
[TBL] [Abstract][Full Text] [Related]
39. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.
Liu W; Zhang B; Hu Q; Qin Y; Xu W; Shi S; Liang C; Meng Q; Xiang J; Liang D; Ji S; Liu J; Hu P; Liu L; Liu C; Long J; Ni Q; Yu X; Xu J
Int J Oncol; 2017 May; 50(5):1792-1800. PubMed ID: 28350132
[TBL] [Abstract][Full Text] [Related]
40. NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity.
Aikemu B; Shao Y; Yang G; Ma J; Zhang S; Yang X; Hong H; Yesseyeva G; Huang L; Jia H; Wang C; Zang L; Sun J; Zheng M
Int J Biol Sci; 2021; 17(7):1716-1730. PubMed ID: 33994856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]